A detailed history of Johnson Financial Group, Inc. transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Johnson Financial Group, Inc. holds 200,000 shares of AMRN stock, worth $118,000. This represents 0.01% of its overall portfolio holdings.

Number of Shares
200,000
Previous 200,000 -0.0%
Holding current value
$118,000
Previous $178,000 22.47%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$1.09 - $1.67 $54,500 - $83,500
50,000 Added 33.33%
200,000 $246,000
Q2 2022

Aug 15, 2022

SELL
$1.13 - $3.69 $565 - $1,845
-500 Reduced 0.33%
150,000 $224,000
Q1 2022

May 16, 2022

BUY
$2.85 - $3.73 $285,000 - $373,000
100,000 Added 198.02%
150,500 $496,000
Q1 2021

May 14, 2021

BUY
$5.03 - $8.8 $251,500 - $440,000
50,000 Added 10000.0%
50,500 $314,000
Q3 2017

Nov 09, 2017

BUY
$3.03 - $3.72 $1,515 - $1,860
500
500 $2,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $238M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Johnson Financial Group, Inc. Portfolio

Follow Johnson Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Johnson Financial Group, Inc. with notifications on news.